Metabolite characterisation in peritoneal dialysis effluent using high-resolution 1H and 1H-13C NMR spectroscopy

被引:31
作者
Guleria, Anupam [1 ]
Bajpai, Nitin Kumar [2 ]
Rawat, Atul [1 ]
Khetrapal, C. L. [1 ]
Prasad, Narayan [2 ]
Kumar, Dinesh [1 ]
机构
[1] Ctr Biomed Res, Lucknow, Uttar Pradesh, India
[2] SGPGIMS, Dept Nephrol, Lucknow, Uttar Pradesh, India
关键词
NMR; metabolites; peritoneal dialysis; peritonitis; pd effluent; H-1-NMR SPECTROSCOPY; METABONOMICS; BIOFLUIDS; DATABASE; RECOMMENDATIONS; IDENTIFICATION; COMPLICATIONS; INFECTIONS; SCLEROSIS; SPECTRA;
D O I
10.1002/mrc.4094
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Metabolite analysis of peritoneal dialysis (PD) effluent may provide information regarding onset and progression of complications associated with prolonged PD therapy. In this context, the nuclear magnetic resonance detectable small metabolites of PD effluent samples were characterised using high-resolution H-1 and H-1-C-13 NMR spectroscopy. The various spectra were recorded (at 800 MHz proton frequency) on PD effluent samples obtained after 4-h (intraperitoneal) dwell time from patients with end-stage renal failure and continuing normally on PD therapy. In spite of devastating spectral feature of PD effluent due to the presence of intense resonances from glucose and lactate, we were able to identify 53 small endogenous metabolites (including many complex coupled spin systems) and more than 90% of the total CH cross peaks of H-1-C-13 heteronuclear single-quantum correlation spectrum specific to various metabolites of PD effluent. We foresee that the characteristic fingerprints of various metabolites of control PD effluent samples will be used to identify and distinguish metabolic differences from PD-related complications. Copyright (C) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 35 条
[1]   MLEV-17-BASED TWO-DIMENSIONAL HOMONUCLEAR MAGNETIZATION TRANSFER SPECTROSCOPY [J].
BAX, A ;
DAVIS, DG .
JOURNAL OF MAGNETIC RESONANCE, 1985, 65 (02) :355-360
[2]   Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [J].
Beckonert, Olaf ;
Keun, Hector C. ;
Ebbels, Timothy M. D. ;
Bundy, Jacob G. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2007, 2 (11) :2692-2703
[3]   NATURAL ABUNDANCE N-15 NMR BY ENHANCED HETERONUCLEAR SPECTROSCOPY [J].
BODENHAUSEN, G ;
RUBEN, DJ .
CHEMICAL PHYSICS LETTERS, 1980, 69 (01) :185-189
[4]   COHERENCE TRANSFER BY ISOTROPIC MIXING - APPLICATION TO PROTON CORRELATION SPECTROSCOPY [J].
BRAUNSCHWEILER, L ;
ERNST, RR .
JOURNAL OF MAGNETIC RESONANCE, 1983, 53 (03) :521-528
[5]   Complications of peritoneal dialysis: Evaluation with CT peritoneography [J].
Cochran, ST ;
Do, HM ;
Ronaghi, A ;
Nissenson, AR ;
Kadell, BM .
RADIOGRAPHICS, 1997, 17 (04) :869-878
[6]   NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology [J].
Coen, Muireann ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) :9-27
[7]   Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS [J].
Duarte, Iola F. ;
Legido-Quigley, Cristina ;
Parker, David A. ;
Swann, Jonathan R. ;
Spraul, Manfred ;
Braumann, Ulrich ;
Gil, Ana M. ;
Holmes, Elaine ;
Nicholson, Jeremy K. ;
Murphy, Gerard M. ;
Vilca-Melendez, Hector ;
Heatond, Nigel ;
Lindon, John C. .
MOLECULAR BIOSYSTEMS, 2009, 5 (02) :180-190
[8]   Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis [J].
Dunn, Warwick B. ;
Summers, Angela ;
Brown, Marie ;
Goodacre, Royston ;
Lambie, Mark ;
Johnson, Tim ;
Wilkie, Martin ;
Davies, Simon ;
Topley, Nick ;
Brenchley, Paul .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (06) :2502-2510
[9]   Continuous ambulatory peritoneal dialysis-a guide to imaging appearances and complications [J].
Goldstein M. ;
Carrillo M. ;
Ghai S. .
Insights into Imaging, 2013, 4 (1) :85-92
[10]  
Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO